3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Active not recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Thoracic
1
Conditions
Squamous Cell Carcinoma of Head and Neck
14
Oropharyngeal Neoplasms
12
Lung Neoplasms
12
Carcinoma, Non-Small-Cell Lung
10
Mouth Neoplasms
8
Laryngeal Neoplasms
8
Carcinoma
8
Small Cell Lung Carcinoma
7
Uterine Cervical Neoplasms
6
Urinary Bladder Neoplasms
6
Ovarian Neoplasms
6
Nasopharyngeal Carcinoma
6
Mesothelioma, Malignant
6
Hypopharyngeal Neoplasms
6
Pancreatic Neoplasms
5
Triple Negative Breast Neoplasms
4
Ganglioneuroblastoma
4
Gallbladder Neoplasms
4
Breast Neoplasms
4
Stomach Neoplasms
3
Salivary Gland Neoplasms
3
Prostatic Neoplasms
3
Neuroblastoma
3
Medulloblastoma
3
Lymphoid Interstitial Pneumonia
3
Fallopian Tube Neoplasms
3
Cholangiocarcinoma
3
Carcinoma, Transitional Cell
3
Adenocarcinoma of Lung
3
Testicular Neoplasms
2
Interventions
tusamitamab ravtansine
1
dacomitinib
1
Platinum
1
Docetaxel
1
Bevacizumab
1
130-nm albumin-bound paclitaxel
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Non-small Cell Lung Cancer Metastatic
×
Platinum
×
1 year
×
Clear all
NCT05407155
2026-04-23
BETTER
Fudan University
Phase NA
Active not recruiting
56 enrolled